logo
A real estate perspective in the Hoosier property tax debate

A real estate perspective in the Hoosier property tax debate

Yahoo17-02-2025

Indiana lawmakers are trying to find a balance between rising property tax bills and local governments' need for revenue to provide services. (Getty Images)
Any Hoosier who has bought or sold a home in recent years can attest to the rising price of putting down roots in Indiana – our statewide median home price is up 60% since 2018 to hit $250,000 in January.
Rising property values are a good thing: Indiana is growing, attracting new residents, employers and investment. And housing budgets still go much further in Indiana, with costs nearly 40% lower than the national average.
But if you aren't in the market to move, the most tangible effect of higher housing prices is higher property assessments and tax bills. For seniors on fixed incomes, young families who have worked their way into starter homes and a growing number of moderate-income Hoosier homeowners, Indiana's growing property tax burden represents a real hardship.
REALTORS® understand the importance of a fair and affordable property tax climate and we've championed significant and lasting residential tax relief through the years. So we're grateful for the leadership of Gov. Mike Braun and the many lawmakers who embrace the cause of pro-homeowner reform.
Senate Bill 1 is a blueprint for reducing homestead taxes. Homeowners have essentially been hit with a $2 billion property tax increase in the past six years, and we support efforts to ease their burden.
But with two-and-a-half months left in this session, there's plenty of debate and discussion left on the topic of property taxes. Senate Bill 1 has already changed significantly, and the House will certainly have their say. With that in mind, we offer a few considerations on behalf of the 21,000 REALTORS® who have long been a leading voice of taxpayers at the Statehouse.
REALTORS® proudly stood with then-Gov. Mitch Daniels to fight for a constitutional cap on homestead property taxes at 1% of a home's assessed value; the caps have saved taxpayers more than $11 billion since 2010.
Current proposals range from targeted relief for certain groups of taxpayers to a broad-based maximum tax liability credit or scaling up homestead assessed value deductions across the board.
The momentum for property tax relief is on the right trajectory, but whatever approach ultimately becomes law, it must preserve uniform and objective methods of taxation – property assessments should fairly reflect value.
Before 2000, Indiana's assessment system was based on arbitrary adjustments to largely outdated estimates of how much a home cost to build. The system bred inequitable taxation, provoked a seven-year court battle and nearly a decade of chaos for taxpayers before 2008. We should learn from this history, and leave artificial caps on assessments out of any serious negotiations on restructuring.
Local officials are concerned about the revenue losses that come with lower property taxes. REALTORS® recognize a healthy balance between cost of living and quality of life: Communities demand and deserve quality public services and physical infrastructure.
But Indiana's system of local government was designed in the age of horse-and-buggy, not high-speed internet. Overlapping layers of government push property taxes rates up while creating a confusion of duplicative bureaucracies.
Eliminating township government, consolidating administrative offices while keeping policymakers accountable to voters and stopping the runaway creation of special taxing districts can all help our cities, counties and school districts live within a limited tax base.
In 2024, 13,000 homes were available across our eight MLS marketplaces on a given day. This number was nearly 40,000 ten years ago. Indiana has underbuilt new homes for more than a decade – since 2014, we've grown by more than 250,000 new households while building less than 173,000 new housing units.
This long-term housing shortage explains why we were already seeing statewide home prices rising faster than the U.S. before the pandemic. Looking ahead, the only sustainable way to keep homeownership affordable and assessments in check is ramping up new home construction to match supply with demand.
We're pleased that the plight of homeowners has taken center stage at the statehouse. REALTORS® have worked with governors, lawmakers and local partners to build one of the nation's most competitive property tax climates – and this year, we see opportunities to put Indiana even further ahead.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Getty Images Stock Was Soaring This Week
Why Getty Images Stock Was Soaring This Week

Yahoo

time31 minutes ago

  • Yahoo

Why Getty Images Stock Was Soaring This Week

A crucial shareholder vote ratified the company's pending merger. It aims to fuse with Shutterstock in a cash-and-stock deal. 10 stocks we like better than Getty Images › Over the past few days, it hasn't been hard to imagine reaping gains on photography services provider Getty Images (NYSE: GETY). After all, the company's stock was a hot item on the market, thanks to a well-received deal to merge with a peer. According to data compiled by S&P Global Market Intelligence, as of late Thursday afternoon, the shares were up by more than 13% week to date. On Tuesday, photo-sharing site operator Shutterstock announced its shareholders had approved -- by a large majority -- their company's pending merger with Getty Images. The vote was roughly 82% in favor of the move. In its press release, Shutterstock wrote that "The combined company will be well-positioned to meet the ever-changing needs of customers through combined investment in content creation, event coverage, and product and technology innovation." The cash-and-stock deal was originally agreed at the start of this year, and although it's been described as a "merger of equals," the Getty Images name will be retained for the combined entity. Also, current Getty Images stockholders will hold nearly 55% of the new business, according to rough calculations. Not that many investors in either company seem to mind -- Shutterstock's equity also popped on news of that shareholder vote. Subsequent to the Shutterstock poll, several insiders in both companies sold off some equity holdings as if to validate the merger and its price. Among these individuals was Getty Images's senior vice president of e-commerce, Daine Weston, who unloaded some of his company's class A common stock, and Shutterstock director Deirdre Bagley, with a sale of 9,700 restricted stock units. Before you buy stock in Getty Images, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Getty Images wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,871!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $875,479!* Now, it's worth noting Stock Advisor's total average return is 998% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Shutterstock. The Motley Fool has a disclosure policy. Why Getty Images Stock Was Soaring This Week was originally published by The Motley Fool Sign in to access your portfolio

Iran launches more than 100 drones at Israel in retaliation for striking nuclear sites: IDF
Iran launches more than 100 drones at Israel in retaliation for striking nuclear sites: IDF

New York Post

timean hour ago

  • New York Post

Iran launches more than 100 drones at Israel in retaliation for striking nuclear sites: IDF

Iran has launched more than 100 drones toward Israel in retaliation for the Jewish state's latest effort to destroy Tehran's nuclear program through a wave of preemptive airstrikes. 'In recent hours, Iran has launched more than 100 drones toward Israeli territory,' IDF spokesman Brigadier General Effie Defrin confirmed Friday. 'We are working to intercept the threats.' The Israeli military has already started to shoot down some of the drones outside of Israeli territory, an IDF spokesman told CNN. 'The IDF has begun intercepting UAVs fired from Iran, outside of Israeli territory,' the official said. 3 Iranian-made Shahed-136 'Kamikaze' drone flies over the sky of Kermanshah, Iran on March 7, 2024. Middle East Images/AFP via Getty Images The retaliation attack by Tehran comes after Israel's Operation 'Rising Lion' targeted several sites across the Iranian capital to dismantle the country's nuclear infrastructure, ballistic missile factories, and military facilities Thursday night. Prime Minister Benjamin Netanyahu said the mission was carried out to prevent Iran from obtaining nuclear weapons and ensure the 'survival' of Israel after 'decades' of Iranian leadership, 'brazenly' calling for his country's destruction. 'We can't leave these threats for the next generation,' Netanyahu said during an address shared on YouTube. 'Because if we don't act now, there will not be another generation. If we don't act now, we simply won't be here. We have internalized the lessons of history. When an enemy says he intends to destroy you — believe him,' he continued. 3 This picture shows the empty al-Aqsa mosque compound in Jerusalem's Old City, on June 13, 2025, after Islam's Friday prayers have been officially canceled. AFP via Getty Images 3 A girl runs to a bomb shelter in an apartment building in Hadera, Israel, Friday, June 13, 2025. AP 'When the enemy develops the capabilities to destroy you — stop him.' Netanyahu vowed to continue strikes 'for as many days as it takes to remove this threat.' The IDF said that approximately 200 Israeli fighter jets participated in the operation, targeting around 100 sites. Iranian officials vowed to deliver a quick retaliation in response to the attacks as the country's Supreme Leader Ayatollah Ali Khamenei said Israel 'should await a harsh response.' with Post wires

Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders
Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders

Business Upturn

time2 hours ago

  • Business Upturn

Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders

By GlobeNewswire Published on June 13, 2025, 11:30 IST Strasbourg (France), June 13, 2025, 8:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors, scientists and leaders of the biotechnology ecosystem during the upcoming editions of: BIO International Convention 2025 , on June 16, in Boston, US; , on June 16, in Boston, US; Portzamparc – 2025 Mid&Small Caps Conference (hosted by BNP Paribas Group ), on June 18, in Paris, France; (hosted by ), on June 18, in Paris, France; International Neoantigen Summit , on June 24, 2025, in Amsterdam, Netherlands; , on June 24, 2025, in Amsterdam, Netherlands; International Academy of Oral Oncology 2025 (IAOO), on July 18, in Liverpool, UK. Following the positive clinical data on our individualized neoantigen cancer vaccine TG4050, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting (see press release here), Transgene together with Prof. Christian Ottensmeier, MD, PhD, FRCP (University of Liverpool, La Jolla Institute for Immunology), have discussed the data presented, the unmet medical need and current treatment landscape for patients suffering from head and neck cancers in a virtual event available on Transgene website and here. *** About Transgene Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company's clinical-stage programs consist of a portfolio of viral vector-based immunotherapeutics. TG4050, the first individualized therapeutic vaccine based on the myvac® platform is the Company's lead asset, with demonstrated proof of principle in patients in the adjuvant treatment of head and neck cancers. The portfolio also includes other viral-vector-based immunotherapies: TG4001 for the treatment of HPV-positive cancers, as well as BT-001 and TG6050, two oncolytic viruses based on the viral backbone. The Company also conducts innovative discovery and preclinical work, aimed at developing novel viral vector-based modalities. With Transgene's myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual. The myvac® approach allows the generation of a virus-based immunotherapy that encodes patient-specific mutations identified and selected by Artificial Intelligence capabilities provided by its partner NEC. With its proprietary platform Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses. Additional information about Transgene is available at: Follow us on social media: X (formerly Twitter): @TransgeneSA — LinkedIn: @Transgene — Bluesky: @Transgene Contacts Disclaimer This press release contains forward-looking statements, which are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. The occurrence of any of these risks could have a significant negative outcome for the Company's activities, perspectives, financial situation, results, regulatory authorities' agreement with development phases, and development. The Company's ability to commercialize its products depends on but is not limited to the following factors: positive pre-clinical data may not be predictive of human clinical results, the success of clinical studies, the ability to obtain financing and/or partnerships for product manufacturing, development and commercialization, and marketing approval by government regulatory authorities. For a discussion of risks and uncertainties which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ('Facteurs de Risque') section of the Universal Registration Document, available on the AMF website ( or on Transgene's website ( Forward-looking statements speak only as of the date on which they are made, and Transgene undertakes no obligation to update these forward-looking statements, even if new information becomes available in the future. Attachment 20250613_Transgene_Upcoming_Events_EN Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store